Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Organ and body health (remove)
Treatment (remove)
- Hepatitis C drugs (remove)
  - Maviret (2)
  - Zepatier (1)

Filter by Infection

Hepatitis C (6)

Filter by Resource Category

Research summary (6)

Search results

Current filters: Treatment, Hepatitis C drugs, Organ and body health

6 search results

Maviret for people with HCV and chronic kidney disease: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
HCV cure and the long road to recovery: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
HCV treatment in advanced liver disease: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
Safety and efficacy of glecaprevir + pibrentasvir (Maviret) in cases of liver or kidney transplant with chronic HCV infection: From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage
Better blood sugar control in people with diabetes after HCV has been cured: From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage
Zepatier in cirrhosis: From TreatmentUpdate 213
2016, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.